|
GNB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.079200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.016700E-03 |
| Normal-vs-Stage2 |
8.904800E-01 |
| Normal-vs-Stage3 |
1.455760E-01 |
| Normal-vs-Stage4 |
1.475210E-01 |
| Stage1-vs-Stage2 |
8.174100E-02 |
| Stage1-vs-Stage3 |
7.95410000000718E-05 |
| Stage1-vs-Stage4 |
3.420800E-04 |
| Stage2-vs-Stage3 |
2.540400E-01 |
| Stage2-vs-Stage4 |
2.361800E-01 |
| Stage3-vs-Stage4 |
8.867600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.611600E-01 |
| Normal-vs-AfricanAmerican |
5.405800E-01 |
| Normal-vs-Asian |
3.906400E-01 |
| Caucasian-vs-AfricanAmerican |
2.090000E-01 |
| Caucasian-vs-Asian |
3.775000E-01 |
| AfricanAmerican-vs-Asian |
1.988980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.763800E-01 |
| Normal-vs-Female |
4.138400E-02 |
| Male-vs-Female |
3.976300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.994800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.854200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.453400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.938790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.435400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.888000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.605840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.572850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.393900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.342420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.480700E-03 |
| Normal-vs-Grade 2 |
3.616300E-04 |
| Normal-vs-Grade 3 |
1.298820E-01 |
| Normal-vs-Grade 4 |
1.102600E-01 |
| Grade 1-vs-Grade 2 |
5.930300E-02 |
| Grade 1-vs-Grade 3 |
1.384990E-04 |
| Grade 1-vs-Grade 4 |
1.365480E-04 |
| Grade 2-vs-Grade 3 |
2.88520000002457E-07 |
| Grade 2-vs-Grade 4 |
5.94179999999778E-05 |
| Grade 3-vs-Grade 4 |
6.493600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.0209999999965E-05 |
| Normal-vs-ccB subtype |
3.351000E-01 |
| ccA subtype-vs-ccB subtype |
1.78019999996781E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.548400E-01 |
| Normal-vs-N1 |
8.547000E-01 |
| N0-vs-N1 |
9.031600E-01 |
|
|
